记载、误导性陈述或重大遗漏。 昆山亚香香料股份有限公司（以下简称"公司"）于 2024 年 8 月 27日召开第 三届董事会第十八次会议与第三届监事会第十六次会议，审议通过《关于调整 2024年限制性股票激励计划授予价格的议案》，现将相关事项说明如下： 证券代码：301220 证券简称：亚香股份 公告编号：2024-042 昆山亚香香料股份有限公司 关于调整 2024 年限制性股票激励计划授予价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 一、本激励计划已履行的决策程序和信息披露情况 1、2024 年 2 月 21 日，公司召开第三届董事会第十五次会议和第三届监事会 第十三次会议，审议通过了《关于〈昆山亚香香料股份有限公司 2024 年限制性股 票激励计划（草案）〉及其摘要的议案》《关于〈昆山亚香香料股份有限公司 2024 年限制性股票激励计划实施考核管理办法〉的议案》等议案，公司召开独立 董事专门会议审议通过了相关议案，律师出具相应报告。 2、2024 年 2 月 22 日至 2024 年 3 月 2 日，公司对 2024 年限制性股票激励 计划首次授予部分激励对象名单与职务 ...

| 编制单位：昆山亚香香料股份有限公司 | | | | | | | | | | 单位：万元 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 司的关联关系 | 上市公司核算 的会计科目 | 2024年初占 用资金余额 | 2024年度占用 累计发生金额 (不含利息) | 2024年度占 用资金的利 息(如有) | 2024年度偿还 累计发生金额 | 2024年末占 用资金余额 | 占用形成原因 | 占用性质 | | 控股股东、实际控制人及 | | | | | | | | - | | | | 其附属企业 | | | | | | | | | | | | 小计 | — | — | — | - | - | - | - | - | | | | 前控股股东、实际控制人 | | | | | | | | - | | | | 及其附属企业 | | | | | | | | | | | | 小计 | — | — | — | - | - | - | - | - | | | | 其他关 ...

| | | 获授予的权 | 占授予权 | 占本激励计划 | | --- | --- | --- | --- | --- | | 姓名 | 职务 | 益数量 | 益总量的 | 公告日公司股 | | | | （股） | 比例 | 本总额的比例 | | 董事会认为需要激励的其他人员（9 | 人） | 116,000 | 13.29% | 0.14% | | 合计 | | 116,000 | 13.29% | 0.14% | 注：1、上述任何一名激励对象通过全部有效的股权激励计划获授的本公司股票均未超过公 司总股本的 1%。公司全部在有效期内的股权激励计划所涉及的标的股票总数累计不超 过公司股本总额的 20%。 昆山亚香香料股份有限公司 2024 年限制性股票激励计划预留部分限制性股票 授予激励对象名单（授予日） 一、2024 年限制性股票激励计划预留部分限制性股票分配情况 2、本计划预留授予部分激励对象不包括独立董事、监事、外籍员工，也不包括单独或 合计持有公司 5%以上股份的股东、公司实际控制人及其配偶、父母、子女。 3、上表中数值若出现总数与各分项数值之和尾数不符，均为四舍五入原因所致。 二、董事会认为需要激励 ...

证券代码: 301220 证券简称:亚香股份 公告编号：2024-040 昆山亚香香料股份有限公司 2024年半年度募集资金存放与使用情况专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管 要求（2022 年修订）》、《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作（2023 年 12 月修订）》以及《深圳证券交易所创业 板上市公司自律监管指南第 2 号——公告格式（2024 年修订）》等的相关规 定，昆山亚香香料股份有限公司（以下简称"公司"）将 2024 年半年度（以下 简称"报告期"）募集资金存放与使用情况专项说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于同意昆山亚香香料股份有限公司首次公开 发行股票注册的批复》（证监许可〔2022〕892 号）核准，并经深圳证券交易所 同意，公司首次向社会公众发行人民币普通股（A 股）股票 2,020.00 万股，每股 面值人民币 1.00 元，发行价格为人民币 ...

证券代码：301220 证券简称：亚香股份 公告编号：2024-039 昆山亚香香料股份有限公司 第三届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 昆山亚香香料股份有限公司（以下简称"公司"）第三届监事会第十六次会议于 2024 年 8 月 27 日在江苏省南通市经济技术开发区通秀路 29 号 3 楼会议室以现场结 合通讯方式召开，会议通知已于 2024 年 8 月 17 日以通讯方式发出。会议由公司监事 会主席徐平先生主持，应出席监事 3 名，实际出席监事 3 名。本次监事会会议的召集、 召开和表决程序符合有关法律法规和《公司章程》的规定。 二、监事会会议审议情况 经与会监事认真审议，形成决议如下： 1、审议通过了《关于<2024 年半年度报告>及其摘要的议案》 监事会认为：董事会编制和审核公司《2024 年半年度报告》及《2024 年半年度报 告摘要》的程序符合相关法律法规、中国证监会和深圳证券交易所的有关规定，报告 内容真实、准确、完整地反映了公司 2024 年半年度的实际情况，不存在虚假记载、误 ...

Financial Performance - The company reported a revenue of 500 million RMB for the first half of 2024, representing a 15% increase compared to the same period last year[7]. - The company's operating revenue for the reporting period was ¥361,125,282.37, representing a 25.62% increase compared to ¥287,467,480.74 in the same period last year[13]. - The net profit attributable to shareholders was ¥35,349,047.66, a decrease of 23.45% from ¥46,180,146.00 in the previous year[13]. - The net profit after deducting non-recurring gains and losses was ¥34,516,177.27, down 9.88% from ¥38,299,855.27 year-on-year[13]. - The net cash flow from operating activities improved significantly to ¥7,151,870.92, compared to a negative cash flow of ¥10,439,259.92 in the same period last year, marking a 168.51% increase[13]. - The total comprehensive income for the first half of 2024 was ¥29,051,970.59, a decrease from ¥47,371,989.48 in the same period of 2023[132]. - The basic earnings per share for the first half of 2024 were ¥0.44, down from ¥0.57 in the first half of 2023[132]. - The company reported a net profit for the first half of 2024 of ¥35,037,570.83, a decrease of 24.1% compared to ¥46,142,324.99 in the first half of 2023[132]. Research and Development - Research and development expenses increased by 25% to 50 million RMB, reflecting the company's commitment to innovation and product development[7]. - Research and development expenses rose by 24.75% to ¥15,799,969.01 from ¥12,665,378.19, reflecting the company's commitment to improving R&D efficiency and innovation capabilities[39]. - The company's research and development efforts are driven by market trends and customer needs, integrating both internal and external resources for product innovation[25]. Market Position and Strategy - User data showed a 20% increase in active customers, reaching 1.2 million by the end of June 2024[7]. - The company plans to launch two new product lines in Q3 2024, focusing on natural flavor enhancers and cooling agents[7]. - Future outlook includes a projected revenue growth of 10-15% for the second half of 2024, driven by market expansion and new product introductions[7]. - The company is exploring potential acquisitions to enhance its market position and product offerings, particularly in the Asia-Pacific region[7]. - The company maintains stable partnerships with international fragrance companies and well-known fast-moving consumer goods brands, ensuring a robust customer base[17]. - The company has established long-term stable cooperation with renowned companies in the fragrance industry, enhancing its market position[17]. Environmental Compliance and Sustainability - The company emphasizes its commitment to sustainability and compliance with international standards in its operations[7]. - The company has established a comprehensive environmental management system and emergency response plan for environmental incidents[88]. - The company has implemented energy management policies to promote energy efficiency and reduce carbon emissions[90]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[90]. - The company has implemented a "no odor enterprise" initiative, enhancing solvent recovery efficiency and improving waste gas treatment[84]. Financial Position and Assets - Total assets at the end of the reporting period were ¥1,965,877,133.00, up 6.89% from ¥1,839,185,281.42 at the end of the previous year[13]. - The total liabilities reached CNY 371,332,375.32, up from CNY 261,901,071.64, representing an increase of approximately 41.7%[126]. - Owner's equity totaled CNY 1,594,544,757.68, compared to CNY 1,577,284,209.78, showing a slight increase of about 1.1%[126]. - The company reported a decrease in cash and cash equivalents to CNY 231,962,796.77 from CNY 264,641,378.14, a decline of approximately 12.3%[127]. Risks and Challenges - The company faces potential risks related to regulatory changes and market competition, which are detailed in the risk management section of the report[2]. - The company faces risks in new product development due to the rapid technological advancements and changing market demands, which require significant investment[65]. - The company has a significant customer concentration risk, with sales to the top five customers accounting for a large proportion of total revenue, which could affect operations if any major customer experiences difficulties[68]. - The company faces risks from fluctuations in raw material prices, particularly for natural and chemical raw materials, which may impact production costs and operational performance[68]. Shareholder Information - The company held three shareholder meetings during the reporting period, with participation rates of 43.26%, 43.55%, and 43.14% respectively[73][74][75]. - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[75]. - The largest shareholder, Zhou Junxue, holds 39.93% of the shares, totaling 32,261,951 shares, with no change during the reporting period[113]. - The company has not encountered any significant legal disputes or non-compliance issues during the reporting period[95]. Investment and Acquisitions - The company completed the acquisition of Wuxue Glamor Biotechnology Co., Ltd. for an investment amount of CNY 216 million, holding a 72% stake[48]. - The company has not reported any investment gains or losses from the recent acquisitions[48]. - The total investment during the reporting period was 297,773,283.30 CNY, a decrease of 56.33% compared to the previous year[47]. Operational Efficiency - The company reported a significant increase in cash flow from operating activities, indicating improved operational efficiency[13]. - The company actively participates in industry conferences to maintain close relationships with existing clients and to explore new customer opportunities[24]. - The company focuses on technological innovation and process improvement to enhance product yield and reduce energy consumption during production[25].

证券代码：301220 证券简称：亚香股份 公告编号：2024-036 昆山亚香香料股份有限公司 2023 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、昆山亚香香料股份有限公司（以下简称"公司"或"本公司"）回购专用证券账户 中的股份 872,900 股不参与本次权益分派。本次权益分派将以公司 2023 年 12 月 31 日 总股本 80,800,000 股扣除公司回购专户中已回购股份 872,900 股后的总股本 79,927,100 股为基数，向全体股东每 10 股派 2.00 元人民币（含税），不进行资本公 积金转增股本和送红股，共计分派现金红利 15,985,420.00 元（含税）。 2、按公司总股本（含回购股份）折算每 10 股现金分红金额=现金分红总额÷公司 总股本×10 股=15,985,420.00 元/80,800,000 股×10 股=1.978393 元(保留六位小数，不四 舍五入，下同)。 二、本次实施的权益分派方案 本公司 2023 年年度权益分派方案为：以截至本次股东大会召开之日公司现 ...

证券代码：301220 证券简称：亚香股份 公告编号：2024-035 昆山亚香香料股份有限公司 2023年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无新增、变更及否决议案的情况； 2、本次股东大会不涉及变更以往股东大会已通过决议的情况。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 现场会议时间：2024年5月13日（星期一）14:00。 网络投票时间：通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投 票的具体时间为：2024年5月13日9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交 易所互联网投票系统（http://wltp.cninfo.com.cn）进行网络投票的具体时间为：2024年 5月13日9:15-15:00期间的任意时间。 2、现场会议召开地点：江苏省南通市经济技术开发区通秀路29号3楼会议室 3、会议召开方式：现场表决与网络投票相结合的方式 4、会议召集人：公司董事会 5、会议主持人：董事长周军学先生 6、会议召开的合法合规 ...

北京市中伦（上海）律师事务所 关于昆山亚香香料股份有限公司 2023 年年度股东大会的 法律意见书 二〇二四年五月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 北京市中伦（上海）律师事务所 关于昆山亚香香料股份有限公司 2023 年年度股东大会的 法律意见书 致：昆山亚香香料股份有限公司 根据《中华人民共和国公司法》（下称"《公司法》"）、《中华人民共和国证券 法》、《上市公司股东大会规则》及其他相关法律、法规、规章和规范性文件，以 及《公司章程》相关规定，北京市中伦（上海）律师事务所（下称"本所 ...

Investment Rating - The report maintains an "Outperform" investment rating for the company, with a target price of RMB 35.42, reflecting a 6% decrease from previous estimates [2][40]. Core Insights - The company's revenue for 2023 was RMB 630 million, a decline of 10.66% year-on-year, with a net profit attributable to shareholders of RMB 80 million, down 39.18% [7][10]. - The decrease in net profit was attributed to changes in downstream market demand and adjustments in product mix, with revenue from synthetic flavors, cooling agents, and natural flavors changing by -18.18%, 19.29%, and -29.53% respectively [7][11]. - The company is expanding its capacity and developing new products, with significant projects underway, including a 300-ton/year Isoamyl Acetate project and a 500-ton/year WS-23 project [7][11]. Financial Performance - The company's gross profit margin (GPM) for synthetic flavors, cooling agents, and natural flavors changed by -9.37, 1.50, and -5.05 percentage points, resulting in GPMs of 16.92%, 33.94%, and 37.20% respectively [7][11]. - Total expenses in sales, management, finance, and R&D increased significantly, with total expense ratio rising by 4.78 percentage points to 19.18% [7][11]. - The projected earnings per share (EPS) for 2024, 2025, and 2026 are RMB 1.54, RMB 2.55, and RMB 3.25 respectively, indicating a recovery in profitability [2][40]. Revenue and Cost Projections - The total revenue is expected to grow to RMB 900 million in 2024, RMB 1.199 billion in 2025, and RMB 1.438 billion in 2026, with corresponding net profits of RMB 124 million, RMB 206 million, and RMB 262 million [6][12]. - The gross profit margin is projected to improve to 33.7% in 2024, 35.7% in 2025, and 37.2% in 2026 [6][12]. Market Position and Competitive Advantage - The company has established strong relationships with well-known domestic and international firms, leveraging its advantages in brand, customer resources, product quality, and technology [11][7]. - As an early developer of natural flavors in China, the company has a robust R&D and production capability, currently able to mass-produce nearly 300 types of flavors, including over 160 natural flavors [11][7].